Vor Biopharma Inc.

NASDAQ:VOR

1.37 (USD) • At close January 15, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -117.863-92.094-68.899-43.337-10.839-4.152
Depreciation & Amortization 3.4922.5251.4340.6050.0910.02
Deferred Income Tax 0000-0.0320.289
Stock Based Compensation 13.36210.6954.3151.3420.1720.116
Change In Working Capital 0.65-12.693-9.1854.3160.1450.063
Accounts Receivables 000000
Inventory 000000
Accounts Payables 2.8500.4055.821.2120.065
Other Working Capital -2.2-12.693-9.59-1.504-1.0670.063
Other Non Cash Items 0.0676.4233.1910.7820.6081.003
Operating Cash Flow -100.292-85.144-69.144-36.292-9.855-2.661
Investing Activities:
Investments In Property Plant And Equipment -1.069-8.462-3.894-4.161-0.7480
Acquisitions Net 000000
Purchases Of Investments -74.923-123.189-87.757000
Sales Maturities Of Investments 14737.560000
Other Investing Activites 0-0-0.088000
Investing Cash Flow 71.008-94.091-91.651-4.161-0.7480
Financing Activities:
Debt Repayment 000002.464
Common Stock Issued 4.578115.975189.19882.26717.6990
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities -1.641.16543.71382.52617.6990
Financing Cash Flow 2.938117.14232.91182.52617.6992.464
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash -26.346-62.09572.11642.0737.096-0.197
Cash At End Of Period 33.77360.119122.21450.0988.0250.929